Highly rated in
Highly rated in
Check Dr. Samuel L. Cooper's experience treating your condition:
About Dr. Samuel L. Cooper

Samuel Cooper is a Radiation Oncologist in Charleston, South Carolina. Cooper has been practicing medicine for over 14 years and is highly rated in 25 conditions, according to our data. His top areas of expertise are Cervical Cancer, Oligodendroglioma, Glioblastoma, and Atypical Teratoid Rhabdoid Tumor ATRT. He is licensed to treat patients in South Carolina. Cooper is currently accepting new patients.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 2 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Samuel L. Cooper it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Samuel L. Cooper accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Molina Healthcare
  •  Absolute Total Care

Call to see if your plan is accepted.
171 Ashley Ave, Charleston, SC 29425
Other Locations
1180 Hospital Dr, Mount Pleasant, SC 29464
2405 N Fraser St, Georgetown, SC 29440
Background & Education
Graduate Institution
Medical University Of South Carolina College Of Medicine, 2008
Radiation Oncology
Internal Medicine in SC
Hospital Affiliations
MUSC Health Black River Medical Center
Medical University Of South Carolina
East Cooper Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
A Traditional Feasibility Study of Gemcitabine, Cisplatin, and 90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors